Patient Condition
MSA-P (Parkinsonian type), primarily presenting with parkinsonism. Progressive bradykinesia and rigidity for 24 months, poor L-dopa response (<30% improvement). Severe orthostatic hypotension and nocturnal stridor. UMSARS-I 22, UMSARS-II 28, SCOPA-AUT 22.
Treatment Timeline
| Phase | Details | Date |
|---|
| Diagnosis assessment | | |
| Drug-optimized treatment | | |
| Intensive rehabilitation treatment | | |
Treatment Outcome
| before | UMSARS-I 22, UMSARS-II 28, severe bradykinesia, frequent wheezing at night |
|---|
| after | UMSARS-I stabilized at 23 points, UMSARS-II improved to 25 points, bradykinesia partially improved, and night wheezing was effectively controlled by CPAP |
|---|
| highlight | High-dose levodopa combined with CPAP effectively improved exercise symptoms and night wheezing, and intensified rehabilitation training further improved exercise function. |
|---|